226 related articles for article (PubMed ID: 6142418)
1. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.
Lambers CB; Lind T; Moberg S; Jansen JB; Olbe L
N Engl J Med; 1984 Mar; 310(12):758-61. PubMed ID: 6142418
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole: a new approach to gastric acid suppression.
Buhl K; Clearfield HR
Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP
Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001
[TBL] [Abstract][Full Text] [Related]
6. Powerful gastric acid inhibition: when is it justified?
Dobrilla G; Amplatz S
Ital J Gastroenterol; 1990; 22 Suppl 1():13-7. PubMed ID: 1983420
[TBL] [Abstract][Full Text] [Related]
7. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
Lamers CB
Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
Lamers CB; Festen HP; van Tongeren JH
Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
Meijer JL; Jansen JB; Lamers CB
Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
[TBL] [Abstract][Full Text] [Related]
11. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome.
McArthur KE; Collen MJ; Maton PN; Cherner JA; Howard JM; Ciarleglio CA; Cornelius MJ; Jensen RT; Gardner JD
Gastroenterology; 1985 Apr; 88(4):939-44. PubMed ID: 3972233
[TBL] [Abstract][Full Text] [Related]
12. [Strong inhibition of gastric acid secretion: when is it justifiable?].
Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
[No Abstract] [Full Text] [Related]
13. H2 receptor antagonists.
Siepler JK; Campagna KD; Donahue PE; Bombeck CT
Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
[TBL] [Abstract][Full Text] [Related]
14. [Omeprazole in the therapy of acid-induced diseases].
Simon B; Dammann HG; Müller P
Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Chelvam P; Wong EC
J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.
Maton PN; Vinayek R; Frucht H; McArthur KA; Miller LS; Saeed ZA; Gardner JD; Jensen RT
Gastroenterology; 1989 Oct; 97(4):827-36. PubMed ID: 2777040
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
[TBL] [Abstract][Full Text] [Related]
19. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
20. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
Leite LP; Just RJ; Castell DO; Lagerström PO
Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]